{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:12:49Z","timestamp":1780942369698,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1053\/j.semnuclmed.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:27:01Z","timestamp":1774528021000},"page":"556-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structured reading for Tau PET Imaging in Alzheimer's disease and related dementias"],"prefix":"10.1053","volume":"56","author":[{"given":"Akintunde T.","family":"Orunmuyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3993-3954","authenticated-orcid":false,"given":"Antoine","family":"Rogeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley M.","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed","family":"Bomanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fraioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimona S.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.semnuclmed.2026.02.005_bib0001","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob Heal"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.02.005_bib0002","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.005_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020189","article-title":"Molecular pathological classification of neurodegenerative diseases: Turning towards precision medicine","volume":"17","author":"Kovacs","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.02.005_bib0004","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158453","article-title":"Biological aging processes underlying cognitive decline and neurodegenerative disease","volume":"132","author":"Gonzales","year":"2022","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.005_bib0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.02.005_bib0006","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.005_bib0007","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of alzheimer\u2019s disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol Aging"},{"issue":"Pt 1","key":"10.1053\/j.semnuclmed.2026.02.005_bib0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.005_bib0009","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/mds.28973","article-title":"Longitudinal Tau positron emission tomography in dementia with lewy bodies","volume":"37","author":"Chen","year":"2022","journal-title":"Mov Disord"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae458","article-title":"18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease","volume":"7","author":"Winer","year":"2024","journal-title":"Brain Commun"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.02.005_bib0011","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1053\/j.semnuclmed.2026.02.005_bib0012","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2967\/jnumed.124.268756","article-title":"Updated appropriate use criteria for amyloid and Tau PET: a report from the Alzheimer\u2019s association and society for nuclear medicine and molecular imaging workgroup","volume":"66","author":"Rabinovici","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.02.005_bib0013","article-title":"Evaluation of a visual interpretation method for tau-PET with 18 F-flortaucipir","author":"Sonni","year":"2020","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.005_bib0014","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00259-021-05673-w","article-title":"International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer\u2019s disease","volume":"49","author":"Tian","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.005_bib0015","first-page":"883","article-title":"Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials","volume":"5","author":"Ossenkoppele","year":"2025","journal-title":"Nat Aging 2025 55"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.02.005_bib0016","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","article-title":"Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline","volume":"28","author":"Ossenkoppele","year":"2022","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2026.02.005_bib0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of Tau Aggregates and Neurodegeneration","volume":"40","author":"Goedert","year":"2017","journal-title":"Annu Rev Neurosci"},{"issue":"Pt 5","key":"10.1053\/j.semnuclmed.2026.02.005_bib0018","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.005_bib0019","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1474-4422(23)00447-7","article-title":"European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders","volume":"23","author":"Frisoni","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2026.02.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2025.121001","article-title":"Pragmatic algorithm for visual assessment of 4-Repeat tauopathies in [18F]PI-2620 PET Scans","volume":"306","author":"Bauer","year":"2025","journal-title":"Neuroimage"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.005_bib0021","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marqui\u00e9","year":"2015","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.02.005_bib0022","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol Psych"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.02.005_bib0023","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.02.005_bib0024","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2967\/jnumed.118.214437","article-title":"Evaluation of 18F-RO-948 PET for quantitative assessment of tau accumulation in the human brain","volume":"59","author":"Kuwabara","year":"2018","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.02.005_bib0025","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00259-019-04399-0","article-title":"18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer\u2019s disease","volume":"46","author":"Sanabria Boh\u00f3rquez","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.005_bib0026","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2967\/jnumed.119.236224","article-title":"Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study","volume":"61","author":"Mueller","year":"2020","journal-title":"J Nucl Med"},{"issue":"13","key":"10.1053\/j.semnuclmed.2026.02.005_bib0027","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1007\/s00259-020-04880-1","article-title":"Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer\u2019s disease","volume":"47","author":"Schmidt","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.005_bib0028","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2967\/jnumed.118.208215","article-title":"Brain imaging of Alzheimer dementia patients and elderly controls with 18F-MK-6240, a PET tracer targeting neurofibrillary tangles","volume":"60","author":"Lohith","year":"2019","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.005_bib0029","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00259-019-04496-0","article-title":"Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948","volume":"47","author":"Smith","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1053\/j.semnuclmed.2026.02.005_bib0030","doi-asserted-by":"crossref","unstructured":"Song M, Scheifele M, Barthel H, et al. Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy. Eur J Nucl Med Mol Imag 2021 4812. 2021;48(12):3872-3885. doi:10.1007\/S00259-021-05391-3","DOI":"10.1007\/s00259-021-05391-3"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.005_bib0031","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of Tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.02.005_bib0032","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2967\/jnumed.118.224113","article-title":"Effect of Off-Target binding on 18F-Flortaucipir variability in healthy controls across the life span","volume":"60","author":"Baker","year":"2019","journal-title":"J Nucl Med"},{"issue":"Pt 9","key":"10.1053\/j.semnuclmed.2026.02.005_bib0033","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.005_bib0034","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat Med"},{"issue":"Pt 5","key":"10.1053\/j.semnuclmed.2026.02.005_bib0035","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.005_bib0036","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2967\/jnumed.122.264371","article-title":"A visual interpretation algorithm for assessing brain tauopathy with 18F-MK-6240 PET","volume":"64","author":"Seibyl","year":"2023","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.005_bib0037","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2967\/jnumed.123.266463","article-title":"Evaluation of neurodegenerative disorders with Amyloid-\u03b2, Tau, and Dopaminergic PET imaging: interpretation pitfalls","volume":"65","author":"Burkett","year":"2024","journal-title":"J Nucl Med"},{"issue":"7_Supplement_1","key":"10.1053\/j.semnuclmed.2026.02.005_bib0038","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1212\/WNL.0000000000212739","article-title":"Comparison of MK-6240 and Flortaucipir Tau PET for the biological staging of Alzheimer disease (P11-4.004)","volume":"104","author":"Medeiros","year":"2025","journal-title":"Neurology"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.02.005_bib0041","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1053\/j.semnuclmed.2026.02.005_bib0042","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease","volume":"157","author":"Maass","year":"2017","journal-title":"Neuroimage"},{"key":"10.1053\/j.semnuclmed.2026.02.005_bib0043","first-page":"243","article-title":"Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [18F]-AV-1451 PET data","author":"Young","year":"2021","journal-title":"Neuroimage"},{"issue":"S9","key":"10.1053\/j.semnuclmed.2026.02.005_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/alz.094084","article-title":"Exploring the effects of using multiple different cerebellar reference regions to improve tau-PET harmonization - The HEAD Study","volume":"20","author":"Bauer-Negrini","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.005_bib0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.02.005_bib0046","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00259-021-05401-4","article-title":"A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis","volume":"48","author":"Leuzy","year":"2021","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1053\/j.semnuclmed.2026.02.005_bib0047","doi-asserted-by":"crossref","unstructured":"Klunk WE, Koeppe RA, Price JC, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11(1):1-15.e4. doi:10.1016\/J.JALZ.2014.07.003","DOI":"10.1016\/j.jalz.2014.07.003"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.02.005_bib0048","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1002\/alz.13908","article-title":"Harmonizing tau positron emission tomography in Alzheimer\u2019s disease: the CenTauR scale and the joint propagation model","volume":"20","author":"Leuzy","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.02.005_bib0049","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","article-title":"Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects","volume":"12","author":"M\u00fcller-G\u00e4rtner","year":"1992","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.005_bib0050","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.005_bib0051","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-011-1745-9","article-title":"The importance of appropriate partial volume correction for PET quantification in Alzheimer\u2019s disease","volume":"38","author":"Thomas","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.02.005_bib0052","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2967\/jnumed.114.148981","article-title":"Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios","volume":"56","author":"Landau","year":"2015","journal-title":"J Nucl Med"},{"issue":"13","key":"10.1053\/j.semnuclmed.2026.02.005_bib0053","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA - J Am Med Assoc"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:54:03Z","timestamp":1780908843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0001299826000474"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.02.005","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structured reading for Tau PET Imaging in Alzheimer's disease and related dementias","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}